Innophos Prices IPO

Innophos Holdings Inc., a Cranbury, N.J.-based specialty phosphates company, priced around 8.7 million common shares at $12 per share ($14-$16 range), for an IPO take of approximately $104.4 million. It will trade on the Nasdaq under ticker symbol IPHS, while Bear Stearns and Credit Suisse served as co-lead underwriters. Bain Capital acquired Innophos in 2004 from Rhodia for $550 million.